Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Dermatology | Monthly Briefing

Back to Journal Articles

May 2012 Briefing - Dermatology

Last Updated: June 01, 2012.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Slow-Growing Melanomas Lose Structure, Vary Color With Time

THURSDAY, May 31 (HealthDay News) -- The diameter of most slow-growing melanomas (SGMs) changes very little over time, but the lesions can become more disorganized, less structured, and change or develop new colors, according to a study published in the June issue of the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Acne Medication Isotretinoin Increases Risk of Eye Disorders

WEDNESDAY, May 30 (HealthDay News) -- The acne medicine isotretinoin may be linked to a nearly two-fold increased risk of ocular adverse effects in users, according to a study published online April 16 in the Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)

NSAID Use Linked to Reduced Risk of Skin Cancer

TUESDAY, May 29 (HealthDay News) -- Nonsteroidal anti-inflammatory drugs (NSAIDs), including nonselective NSAIDs and older cyclooxygenase (COX)-2 inhibitors, are associated with a decreased risk of squamous cell carcinoma (SCC) and malignant melanoma (MM), particularly among long-term and high-intensity NSAID users, according to a study published online May 29 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Common Therapies for Basal Cell Carcinoma Offer Similar Survival

FRIDAY, May 25 (HealthDay News) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published online May 21 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Vemurafenib, Dabrafenib Linked to Cutaneous Side Effects

THURSDAY, May 24 (HealthDay News) -- The selective small molecule inhibitors of BRAF, vemurafenib and dabrafenib, are associated with diverse cutaneous side effects, including both malignant and benign growths, when used to treat patients with melanoma with the BRAF V600E mutation, according to research published online May 21 in the Journal of the American Academy of Dermatology.

Emily Y. Chu, M.D., Ph.D., of the Hospital of the University of Pennsylvania in Philadelphia, and colleagues evaluated the cutaneous adverse effects of vemurafenib and dabrafenib in 13 patients being treated for metastatic melanoma and one patient being treated for metastatic thyroid cancer.

Abstract
Full Text (subscription or payment may be required)

Hair Loss Pathology Identified in Pityriasis Versicolor Lesions

TUESDAY, May 22 (HealthDay News) -- Patients with pityriasis versicolor (PV) lesions may experience hair thinning and/or loss within the lesion, according to a study published online May 10 in the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Vigorous Physical Activity Tied to Reduced Psoriasis Risk

TUESDAY, May 22 (HealthDay News) -- Vigorous physical activity is associated with a reduced risk of psoriasis in women, according to a study published online May 21 in the Archives of Dermatology.

Abstract
Full Text

Dabrafenib Safe, Active Against Some Metastatic Melanomas

MONDAY, May 21 (HealthDay News) -- Dabrafenib, the mutant BRAF-selective inhibitor of BRAF kinase, is safe for treating solid tumors and shows antitumor activity against Val600-mutant BRAF melanomas and other solid tumors, including melanomas that have metastasized to the brain, according to a study published in the May 19 issue of The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Epidemiology of Rosacea Described in United Kingdom

FRIDAY, May 18 (HealthDay News) -- The incidence of rosacea in the United Kingdom is 1.65 per 1,000 person-years, with alcohol consumption linked to a modest increase in risk and current smoking linked to an decreased risk, according to a study published online May 5 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Sunscreen Ingredient May Be Linked to Risk of Endometriosis

FRIDAY, May 18 (HealthDay News) -- Benzophenone (BP)-type derivatives may be linked to an increased risk of endometriosis, according to a study published in the April 17 issue of Environmental Science & Technology.

Abstract
Full Text (subscription or payment may be required)

PET More Sensitive Than CT for Merkel Cell Carcinoma

TUESDAY, May 15 (HealthDay News) -- Fluorine-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) is significantly more sensitive and equally specific compared with traditional computed tomography (CT) imaging for evaluation of the regional lymph node basin in patients with Merkel cell carcinoma (MCC), according to research published online May 2 in the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Higher Melanoma Mutation Rate Tied to Chronic Sun Exposure

FRIDAY, May 11 (HealthDay News) -- Metastatic melanomas from patients with chronic sun exposure have higher mutation rates, and a single gene is mutated in 14 percent of metastatic melanomas, according to a study published online May 9 in Nature.

Full Text

Sun Protective Behavior on the Rise in U.S. Adults

THURSDAY, May 10 (HealthDay News) -- Adults in the United States may be taking more precautions to avoid sunburn outdoors, but many are still getting burned, and a substantial proportion are utilizing indoor tanning, according to research published in the May 11 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Full Text 1
Full Text 2

Sun/Skin Cancer Counseling Recommended for Youth

TUESDAY, May 8 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends that physicians counsel children, adolescents, and young adults who have fair skin about ultraviolet radiation exposure and skin cancer prevention, according to new recommendations published online May 7 in the Annals of Internal Medicine.

Abstract
Full Text

Methodological Heterogeneity Seen in Clinical Trials

TUESDAY, May 1 (HealthDay News) -- Clinical studies registered with ClinicalTrials.gov from 2007 and 2010 are predominately small, single-center trials and contain significant heterogeneity in methodology, according to a study published in the May 2 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Food Allergy Risk Up for Children Born in the Fall

TUESDAY, May 1 (HealthDay News) -- Children born in the fall have an increased risk of food allergy, with a significantly increased risk seen only for Caucasians and those with eczema, according to a study published online April 19 in Allergy.

Abstract
Full Text (subscription or payment may be required)

Women Have Clear Melanoma Survival Advantage Over Men

TUESDAY, May 1 (HealthDay News) -- Women with localized melanoma have a consistent advantage over men of approximately 30 percent for survival and progression, according to a study published online April 30 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Copyright © 2012 ScoutNews, LLC. All rights reserved.


Previous: May 2012 Briefing - Cardiology Next: May 2012 Briefing - Diabetes & Endocrinology

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.